Orthocell Ltd has released a press release.
Surgical Specialties Appointed as Exclusive Distributor
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Orthocell
- Celgro Positive Safety and Performance in Human Hip Study
- 1st Patient Recruited in Ortho-ATI Shoulder Tendon Study
- Preliminary Final Report
- Ortho-ACI on Australian Register of Therapeutic Goods
- Ethics Approval Received for Pilot Ortho-ATI Tendon Study
Later from Orthocell
- Notice of Annual General Meeting/Proxy Form
- Orthocell Granted CelGro Patent Protection in Canada
- Orthocell receives R&D tax incentive refund
- Orthocell Receives CE Mark for CelGro
- Orthocell Granted European Cartilage Regeneration Patent
Follow Orthocell into a list and get an email when it puts out news.
Follow Orthocell